Cargando…
SARS-CoV-2 variants reveal features critical for replication in primary human cells
Since entering the human population, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; the causative agent of Coronavirus Disease 2019 [COVID-19]) has spread worldwide, causing >100 million infections and >2 million deaths. While large-scale sequencing efforts have identified numero...
Autores principales: | Pohl, Marie O., Busnadiego, Idoia, Kufner, Verena, Glas, Irina, Karakus, Umut, Schmutz, Stefan, Zaheri, Maryam, Abela, Irene, Trkola, Alexandra, Huber, Michael, Stertz, Silke, Hale, Benjamin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021179/ https://www.ncbi.nlm.nih.gov/pubmed/33760807 http://dx.doi.org/10.1371/journal.pbio.3001006 |
Ejemplares similares
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Busnadiego, Idoia, et al.
Publicado: (2020) -
Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense
por: Fernbach, Sonja, et al.
Publicado: (2022) -
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
por: Pohl, Marie O., et al.
Publicado: (2021) -
Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office
por: Weissberg, Dana, et al.
Publicado: (2020) -
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
por: Busnadiego, Idoia, et al.
Publicado: (2022)